Rituximab
monoclonal antibody · anticancer
Nothing to addWhat this medicine is for
Rituximab belongs to the category “monoclonal antibody (anticancer)”. This medicine belongs to the “Other fields” field. Its indication is precise and set by the prescription.
In the case of Rituximab, this means: Treats a cancer. How it is used is determined case by case with the professional who prescribes it.
Under which brands it is found
Rituximab is part of about 4 presentations listed in France. It comes under various trade names and as generics.
- Mabthera
- Rixathon
- Ruxience
- Truxima
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
For Rituximab, we offer no supplement. No nutritional supplementation is seriously justified as an addition to this treatment, and we would rather write that than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; outside of those, we do not sell for the sake of selling, and that is what gives weight to our five products.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Other areas » family and its neighbours.